Tag: Imaging Devices
Neuroimaging Use in Ischemic Stroke Examined for Medicare Patients
Neuroimaging performed less often among ischemic stroke patients who are female, 80 years of age or older, Black, or rural
Aspirin Use Not Tied to Clinical Outcomes in Nonobstructive CAD
Statin use linked to reduced risk for major adverse cardiovascular events in individuals with nonobstructive coronary artery disease
Consider COVID Vax History When Assessing Adenopathy on Mammo
Axillary lymphadenopathy more likely within 14 days after vaccination; persistent axillary lymphadenopathy seen up to 43 weeks later
CT Compared With ICA for Evaluating Stable Chest Pain
Risk for major adverse CV events similar with CT versus invasive coronary angiography as initial imaging for the diagnosis of obstructive CAD
AI Model May Identify Thyroid Cancer from Ultrasound Images
Artificial intelligence platform combines multiple methods, including radiomics, topological data analysis, deep learning, and machine learning
Breast Arterial Calcification on Mammography Tied to CVD Risk
The presence of breast arterial calcification on routine mammography in postmenopausal women may indicate increased cardiovascular risk
AI Algorithm Accurately IDs Two Life-Threatening Heart Conditions
Model can distinguish between hypertrophic cardiomyopathy and cardiac amyloidosis using ultrasound videos
Neuroimaging Measures Linked to Stages of Memory Impairment
Presence of Alzheimer disease pathology related to Stages of Objective Memory Impairment in cognitively unimpaired older adults
EUS-Guided Drainage Studied in Noncholecystitis Gallbladder Disease
EUS-GBD has potential for nonoperative management of gallstone disease in patients with noncholecystitis gallbladder-related disease
Brain Imaging May ID THC-Linked Impairment in Cannabis Users
Measurement of prefrontal cortex oxygenated hemoglobin concentration with functional near-infrared spectroscopy may detect THC impairment